Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

<div>Histological section of mouse lymphoid tissue on day 70, stained with haematoxylin-eosin: (a) histology of mouse normal lymphoid tissue treated with saline solution (100x); (b) lymphoid tissue from a mouse treated with IMPIPS+adjuvant having nodular hyperplasia (100x).</div>

Journal of Immunology Research

fig6

Figure 6

Figure 6: Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model 

Figure 6 | Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model 